Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?

Atherosclerosis - 1 Jul 1999

Byrne C D

Abstract excerpt

Specific treatment that primarily reduces low density lipoprotein cholesterol (LDLc) levels improves survival of patients with pre-existing vascular disease by 20-30%. Failure to produce a more marked improvement in outcome is most likely explained by: (1) the observation from angiographic studies that established atherosclerotic vascular disease (AVD) is largely irreversible with current therapy and (2) other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Blood Coagulation
Share to Blood Vessels

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinolysis

Share to Hemostasis

Share to Lipoproteins

Share to NF-kappa B

Share to Platelet Activation

Source

Identifiers

PMID: 10428291
DOI: 10.1016/s0021-9150(99)00110-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?PMID 10428291Read ↗

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.Semantic proximity Read ↗

Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.Semantic proximity Read ↗

Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.Semantic proximity Read ↗

Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment.Semantic proximity Read ↗

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factorSemantic proximity Read ↗

Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Semantic proximity Read ↗

Characterization of the inflammatory phenotype in atherosclerosis may contribute to the development of new therapeutic and preventative interventions.Semantic proximity Read ↗

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.Semantic proximity Read ↗

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2Semantic proximity Read ↗

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read ↗

Differential platelet oxidation-inflammatory phenotype in coronary artery disease versus peripheral artery disease supports diverse pathophysiological processesSemantic proximity Read ↗

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.